Kenneth A. Krohn
#153,046
Most Influential Person Now
Kenneth A. Krohn's AcademicInfluence.com Rankings
Kenneth A. Krohnengineering Degrees
Engineering
#6260
World Rank
#7576
Historical Rank
Biomedical Engineering
#540
World Rank
#550
Historical Rank
Kenneth A. Krohncomputer-science Degrees
Computer Science
#8202
World Rank
#8624
Historical Rank
Computer Graphics
#164
World Rank
#169
Historical Rank
Download Badge
Engineering Computer Science
Why Is Kenneth A. Krohn Influential?
(Suggest an Edit or Addition)Kenneth A. Krohn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. (1996) (581)
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. (1992) (482)
- Molecular Imaging of Hypoxia (2008) (348)
- Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. (2006) (344)
- Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer (2006) (329)
- Imaging oxygenation of human tumours (2006) (328)
- Hypoxia and Glucose Metabolism in Malignant Tumors (2004) (322)
- Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. (1989) (312)
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. (1983) (290)
- Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. (1995) (285)
- Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival (2008) (261)
- [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression (2003) (243)
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol (2008) (232)
- Carbon-11-thymidine and FDG to measure therapy response. (1998) (232)
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development (2005) (228)
- Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. (1984) (219)
- FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. (2005) (209)
- Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. (1989) (203)
- FDG-PET prediction of head and neck squamous cell cancer outcomes. (2004) (198)
- Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. (1987) (198)
- Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. (2011) (172)
- 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. (2004) (171)
- Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. (2009) (166)
- Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. (2005) (161)
- PET imaging of cellular proliferation. (2005) (157)
- Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. (2005) (155)
- Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond (2007) (151)
- Utilization of labeled thymidine in DNA synthesis: studies for PET. (1990) (150)
- Imaging hypoxia and angiogenesis in tumors. (2005) (149)
- Tumor Receptor Imaging (2008) (145)
- Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas (2008) (140)
- Validity of microsphere depositions for regional myocardial flows. (1987) (138)
- Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. (2006) (137)
- 2-[C-11]thymidine imaging of malignant brain tumors. (1999) (137)
- Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. (1998) (136)
- Staging of head and neck squamous cell cancer with extended-field FDG-PET. (2003) (135)
- Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody. (1985) (133)
- FDG‐PET/CT–guided intensity modulated head and neck radiotherapy: A pilot investigation (2005) (130)
- Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. (2003) (128)
- Imaging and treatment of B-cell lymphoma. (1990) (124)
- A radiosynthesis of fluorine-18 fluoromisonidazole. (1989) (124)
- Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. (2005) (119)
- Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. (1998) (117)
- A Robust Automated Measure of Average Antibody Staining in Immunohistochemistry Images (2010) (117)
- Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Breast Cancer (2011) (114)
- Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. (1984) (112)
- Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model. (1992) (111)
- Hypoxia imaging-directed radiation treatment planning (2006) (102)
- Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. (1985) (102)
- The FDG lumped constant in normal human brain. (2002) (101)
- Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation. (2002) (100)
- Molecular and particulate depositions for regional myocardial flows in sheep. (1990) (99)
- Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomography. (2004) (98)
- F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. (2015) (97)
- Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. (1992) (93)
- Systematic screening of potential β-cell imaging agents (2004) (91)
- Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. (1985) (91)
- Synthesis and characterization of congeners of misonidazole for imaging hypoxia. (1987) (89)
- Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging (2015) (89)
- Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience. (1985) (89)
- Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. (1992) (87)
- Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2. (1997) (87)
- Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies. (1999) (85)
- Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding. (1984) (84)
- Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [F]Fluoromisonidazole and [F]Fluorodeoxyglucose Positron Emission Tomography Imaging (2004) (83)
- [18F]fluoroestradiol radiation dosimetry in human PET studies. (2001) (82)
- A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET (2015) (82)
- Site-Specific Labeling of Annexin V with F-18 for Apoptosis Imaging (2008) (80)
- Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. (1996) (79)
- Imaging Cellular Proliferation as a Measure of Response to Therapy (2001) (79)
- Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. (1991) (79)
- 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. (2003) (78)
- Production of [F-18]fluoroannexin for imaging apoptosis with PET. (2004) (78)
- [11C]Metahydroxyephedrine and [18F]Fluorodeoxyglucose Positron Emission Tomography Improve Clinical Decision Making in Suspected Pheochromocytoma (2006) (77)
- True tracers: comparing FDG with glucose and FLT with thymidine. (2005) (76)
- Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer (2016) (73)
- Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution. (1984) (71)
- Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies. (1986) (71)
- NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies (2009) (70)
- Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. (1997) (69)
- Non-invasive imaging of beta cell mass: a quantitative analysis. (2004) (68)
- Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by ( 18 F)Fluoromisonidazole and ( 18 F)Fluorodeoxyglucose Positron (2004) (68)
- Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET (2011) (66)
- Differences in the sites of iodination of proteins following four methods of radioiodination. (1977) (66)
- Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium. (1989) (65)
- 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome. (2002) (64)
- Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts. (1990) (61)
- Identifiability Analysis of an In Vivo Receptor-Binding Radiopharmacokinetic System (1985) (59)
- Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia. (1987) (56)
- Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images. (2011) (55)
- Dynamic perifusion to maintain and assess isolated pancreatic islets. (2002) (55)
- PET radiopharmaceuticals: state-of-the-art and future prospects. (1998) (54)
- THE SYNTHESIS OF 13N LABELED AMMONIA, DINITROGEN, NITRITE, AND NITRATE USING A SINGLE CYCLOTRON TARGET SYSTEM (1978) (53)
- Systematic screening of potential beta-cell imaging agents. (2004) (52)
- Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. (1986) (52)
- High-level iodination of monoclonal antibody fragments for radiotherapy. (1984) (51)
- Continuing Education: Multi-modality Brain Tumor Imaging – MRI, PET, and PET/MRI (2015) (49)
- Melanoma localization in nude mice with monoclonal Fab against p97. (1985) (49)
- [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. (2006) (49)
- Studies of radioiodinated fibrinogen. II. Lactoperoxidase iodination of fibrinogen and model compounds. (1974) (49)
- Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors. (2001) (48)
- Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913). (1985) (45)
- Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH. (1980) (45)
- Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion. (1990) (43)
- Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method? (2003) (42)
- In vitro measurement of avidity of radioiodinated antibodies. (1987) (42)
- Determination of the Deoxyglucose and Glucose Phosphorylation Ratio and the Lumped Constant in Rat Brain and a Transplantable Rat Glioma (1989) (42)
- Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies. (1983) (42)
- A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites. (1996) (42)
- Fluoromisonidazole. A metabolic marker of myocyte hypoxia. (1990) (41)
- Interpreting enzyme and receptor kinetics: keeping it simple, but not too simple. (2003) (41)
- Applications of PET imaging with the proliferation marker [18F]-FLT. (2015) (40)
- Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. (1987) (39)
- Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. (1987) (39)
- Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake. (2004) (38)
- High dose radiolabeled antibody therapy of lymphoma. (1990) (38)
- 89Zr for antibody labeling and positron emission tomography (1986) (38)
- Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells (2010) (38)
- Myocardial extraction and retention of 2-iododesmethylimipramine: a novel flow marker. (1986) (36)
- Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy. (2007) (36)
- Unsatisfactory biologic behavior of I-fibrinogen labeled by the chloramine-T method. (1973) (36)
- Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging. (1991) (35)
- Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors. (1986) (35)
- Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia. (1993) (34)
- Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient results. (2002) (34)
- 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions (2015) (34)
- Specific protection of different normal tissues. (1988) (33)
- Multiagent PET for Risk Characterization in Sarcoma (2011) (32)
- Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol (2018) (32)
- Quantitation of presynaptic cardiac sympathetic function with carbon-11-meta-hydroxyephedrine. (1998) (31)
- Short-lived radionuclides in chemistry and biology (1982) (30)
- Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection. (1986) (30)
- Nonparametric Residue Analysis of Dynamic PET Data With Application to Cerebral FDG Studies in Normals (2009) (30)
- Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. (1995) (29)
- Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies. (1988) (28)
- Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: compartmental model investigation and mathematical analysis. (2002) (28)
- Deoxyglucose Lumped Constant Estimated in a Transplanted Rat Astrocytic Glioma by the Hexose Utilization Index (1990) (28)
- Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689). (1986) (27)
- Bromomisonidazole: synthesis and characterization of a new radiosensitizer. (1982) (26)
- Kinetic Quantitation of Cerebral PET-FDG Studies Without Concurrent Blood Sampling: Statistical Recovery of the Arterial Input Function (2010) (25)
- Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells. (1985) (24)
- Low energy cyclotron production and separation of yttrium-86 for evaluation of monoclonal antibody pharmacokinetics and dosimetry (1999) (23)
- Radiopharmaceuticals for thrombus detection: selection, preparation, and critical evaluation. (1977) (23)
- Tumor receptor imaging: proceedings of the National Cancer Institute workshop, review of current work, and prospective for further investigations. (1995) (23)
- The Validity of 99mTc-Pyridoxylideneglutamate (P.G.) Cholescintigraphy as a Diagnostic Test for Cholecystitis (1978) (22)
- Chemistry of Nuclear Recoil 18F Atoms. IV. Hot F‐to‐HF and F‐to‐F2 Abstraction in CH3CF3 (1971) (21)
- Autoradiolysis of iodinated monoclonal antibody preparations. (1986) (21)
- [18F]-2-fluoro-2-deoxyglucose transport kinetics as a function of extracellular glucose concentration in malignant glioma, fibroblast and macrophage cells in vitro. (2004) (21)
- Biliary tract scanning with 99Tc(m) pyridoxylideneglutamate: A new gallbladder scanning agent (1976) (21)
- A new synthesis of the labeling precursor for [18F]- fluoromisonidazole (2005) (20)
- Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice. (1977) (20)
- Radioprotection against cataract formation by WR-77913 in gamma-irradiated rats. (1986) (19)
- Radiochemical quality control of short-lived radiopharmaceuticals. (1977) (19)
- Mechanism of Morphine‐Induced Shifts in Blood Volume between Extracorporeal Reservoir and the Systemic Circulation of the Dog under Conditions of Constant Blood Flow and Vena Caval Pressures (1978) (19)
- Goodness-of-fit and local identifiability of a receptor-binding radio-pharmacokinetic system (1992) (19)
- Technetium-99m pyridoxylideneglutamate (P.G.) cholescintigraphy. (1976) (19)
- Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization? (2019) (19)
- A simple thick target for production of 89Zr using an 11MeV cyclotron. (2017) (18)
- Comparison of oncophilic radiopharmaceuticals, *I‐fibrinogen, 67Ga‐ citrate, 111In‐bleomycin, and *I‐bleomycin in tumor‐bearing mice (1977) (18)
- Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model. (2005) (18)
- Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression. (2016) (18)
- VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLES. (2014) (18)
- NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of FLT as a Marker of Proliferation in Patients with Recurrent Gliomas: Safety Studies (2008) (18)
- Chemistry of Nuclear Recoil 18F Atoms. V. Mechanism and Systematics in CH3CF3 (1971) (17)
- Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma. (1997) (17)
- What is in a number? The FDG lumped constant in the rat brain. (2007) (17)
- Evaluation of alternative approaches for imaging cellular growth. (2001) (17)
- Molecular imaging of regional brain tumor biology (2002) (17)
- The search for a gamma-emitting estrogenic ligand. (1980) (16)
- Positron emission tomography: imaging tumor response (2000) (16)
- Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: comparison with prior results with phosphorothioates. (1995) (15)
- The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells. (2012) (15)
- Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic? (2005) (15)
- Challenges in clinical studies with multiple imaging probes. (2007) (15)
- Preparation and chemical characterization of radioiodinated bleomycin. (1975) (15)
- Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I. (1991) (14)
- Positron emission tomography-guided conformal fast neutron therapy for glioblastoma multiforme. (2008) (14)
- Inhibition of lens opacification in x-irradiated rats treated with WR-77913. (1986) (14)
- Radiosynthesis of 6-[C-11]-D-glucose. (1993) (13)
- Monitoring Targeted Therapy: Is Fluorodeoxylucose Uptake a Marker of Early Response? (2006) (13)
- High-dose radioimmunotherapy of B cell lymphomas. (1990) (13)
- Chemistry of Nuclear Recoil 18F Atoms. VI. Approximate Energetics and Molecular Dynamics in CH3CF3 (1971) (13)
- Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor models. (1997) (13)
- The physical chemistry of ligand-receptor binding identifies some limitations to the analysis of receptor images. (2001) (13)
- 1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies. (1998) (12)
- Quantifying Hypoxia with Radiolabeled Fluoromisonidazole: Pre-Clinical and Clinical Studies (1999) (12)
- Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids. (1984) (12)
- Effect of the Radioprotector WR2721 on Irradiation-Induced Injury to Ciliated Cells of Eustachian Tube (1992) (12)
- National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
- Assessment of the Prognostic Value of Radiomic Features in 18F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial (2020) (12)
- In vivo kinetics of hepatobiliary agents in jaundiced animals (1979) (11)
- Kinetic Analysis of 2-[11C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Preliminary Patient Results (2002) (11)
- High speed liquid chromatography of phenylethanolamines for the kinetic analysis of [11C]-meta-hydroxyephedrine and metabolites in plasma. (1997) (11)
- The use of 50 MeV protons to produce C-11 and O-15 (1986) (11)
- Toxicity and biodistribution of the radioprotectors, WR2721, WR77913, and WR3689, in the CNS following intraventricular or intracisternal administration. (1986) (11)
- 18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer (2020) (10)
- In Vitro Analysis of Transport and Metabolism of 4'-Thiothymidine in Human Tumor Cells (2014) (10)
- Glioma FMISO PET/MR Imaging Concurrent with Antiangiogenic Therapy: Molecular Imaging as a Clinical Tool in the Burgeoning Era of Personalized Medicine (2016) (10)
- The Use of Isotopic Nitrogen as a Biochemical Tracer (1982) (10)
- Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo. (2012) (10)
- Significance of limiting low pressure product yields from energetic atomic exchange reactions (1975) (10)
- WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cord. (1988) (10)
- Hypoxia mediated binding of misonidazole in non-malignant tissue. (1986) (9)
- Second generation hypoxia imaging agents. (1993) (9)
- Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor. (1986) (9)
- Design and Validation of a Radiochromatogram Scanner with Analog and Digital Output (1980) (8)
- Sources of carrier F-19 in F-18 fluoride (2012) (8)
- Multinuclear NMR studies of an actively dividing artificial tumor. (2002) (8)
- PET Imaging of Response and Resistance to Cancer Therapy (2006) (7)
- Kinetic Analysis of 2-[11C]Thymidine PET Imaging Studies of Malignant Brain Tumors: Compartmental Model Investigation and Mathematical Analysis (2002) (7)
- TREATMENT OF B‐CELL LYMPHOMA WITH I‐131 LABELED MURINE MONOCLONAL ANTIBODIES.: P10 (1987) (7)
- A radiosynthesis of [F‐18]fluoromisonidazole (1989) (7)
- I-fibrinogen as an oncophilic radiodiagnostic agent: distribution kinetics in tumour-bearing mice. (1977) (7)
- Improving the tumor retention of radioiodinated antibody (1990) (6)
- Imaging Hypoxia with 18F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis (2016) (6)
- Reactions of recoil iodine formed by the xenon-125 .far. iodine-123 system with simple hydrocarbons. II. Pressure studies on the methane and ethane systems (1973) (6)
- Comparison of I-bleomycin prepared by two methods stability and pharmacokinetics in tumor-bearing mice. (1977) (6)
- Synthesis of tritiated diborane and cryptand [2.2.2] (1990) (6)
- High-Dose Radioimmunotherapy of B Cell Lymphomas1 (1989) (6)
- Co-registered FDG-PET/CT imaging for staging and IMRT treatment planning for squamous cell carcinoma of the head and neck (2003) (6)
- Catabolism and protein binding of Tc-99m pyridoxylideneglutamate. (1978) (6)
- A Metabolic Marker of Myocyte Hypoxia (2005) (5)
- Synthesis and radiobiological applications of [35S]L-homocysteine thiolactone. (1990) (5)
- Myocardial extraction and retention of 2-iododesmethylimipramine (1986) (5)
- PET Imaging for Tumor Hypoxia: Characterizing the Tumor and Guiding Treatment (2006) (5)
- Magnetic resonance spectroscopic measurement of cellular thiol reduction-oxidation state. (1992) (5)
- Intramolecular effects of radioiodine decay in o-iodophenol, a model for radioiodinated proteins. (1975) (5)
- Antibody deposition in tumor in relation to blood clearance using a nephrectomized mouse model (1985) (5)
- A 3He++ radio-frequency quadrupole accelerator for positron emission tomography (1990) (5)
- Irradiation of water to improve 15O-specific activity (1991) (5)
- Production of PET radionuclides using a 10.5 MeV {sup 3}He RFQ accelerator (1999) (4)
- 18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study (2021) (4)
- In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689. (1988) (4)
- Nitrate uptake by phytoplankton: measurements utilizing the radiotracer 13N: With 2 figures and 1 table in the text (1978) (4)
- Error analysis of regional measurements of hepatic receptor biochemistry via PET observations of 68Ga]-deferoxamine-galactosyl-neoglycoalbumin kinetics (1989) (4)
- Denitrification studies with /sup 13/N-labeled nitrate (1976) (4)
- Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913. (1990) (4)
- Measurement of tissue oxidation-reduction state with carbon-13 nuclear magnetic resonance spectroscopy. (1989) (4)
- Radioactive labeling of protein carboxyl groups on factor VIII: use of carbodiimides for nuclear medicine. (1977) (4)
- A mathematical model for glioma growth and invasion links biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET (2007) (4)
- Addendum to ‘A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET’ (2015) (4)
- Abstract SY42-02: Novel PET imaging in the clinic: Selecting patient cohorts and measuring early response (2012) (3)
- Analyzing the results of 18FMISO PET hypoxia imaging What is the best way to quantify hypoxia (2002) (3)
- The power of the atom (2014) (3)
- Oxygen transport in the myocardium (1992) (3)
- Regional FDG Lumped Constant in the Normal Human Brain (2001) (3)
- Analysis of myocardial and total body integral extraction ratios of rubidium-86. (1978) (3)
- L or D/L tryptophan for pancreas scintigraphy? (1978) (3)
- Binding of aminoalkylphosphorothioate radioprotective drugs to rodent tissue proteins. (1990) (3)
- Novel imaging approaches to head and neck cancer. (2008) (3)
- Quantitative [F-18]-fluoromisonidazole (FMISO) imaging of hypoxia using image-based blood surrogates (2012) (2)
- [18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab. (2022) (2)
- Bayesian use of historical data to guide blood input function extraction from dynamic PET studies (2007) (2)
- Understanding resistance to hormonal therapy in estrogen avid breast cancer. (2006) (2)
- Use of serial 18F-Fluorothymidine (FLT) PET and Ki-67 to predict response to aromatase inhibitors (AI) in women with ER+ breast cancer. (2016) (2)
- Synthesis and radioiodination of ten aryl‐carbohydrate compounds for labeling monoclonal antibodies (1990) (2)
- Site of iodination of bleomycin (1979) (2)
- Biodistribution studies of labeled tryptophan: a potential pancreas-scanning agent. (1978) (2)
- Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation. (2020) (2)
- Liver imaging via labeled hepatic binding protein ligands (1978) (2)
- Characterization of 4-bromomisonidazole as a radiosensitizer and a potential detector of hypoxic cells (1982) (2)
- In-target chemistry during the production of 15O and 11C using 3He reactions (2000) (2)
- 18F-Fluoroestradiol (FES) and 18F-Fluorodeoxyglucose (FDG) PET imaging in lobular breast cancer. (2018) (2)
- Tumor localization in animals and patients using radioiodinated bleomycin (1975) (2)
- The Predictive Utility of PET-Misonidazole in Locally Advanced Head and Neck Cancer Treated with Radiotherapy (2007) (1)
- Tc‐99m LABELED MONOCLONAL ANTIBODIES FOR IMAGING METASTATIC DISEASE.: A4 (1986) (1)
- Will we be able to recognize a better antibody radiopharmaceutical when we make it? (1990) (1)
- Radiopharmaceuticals for the Study of Liver and Renal Function (2005) (1)
- [F-18]-fluoromisonidazole (FMISO) PET demonstrates reduced hypoxia in recurrent malignant gliomas that respond to bevacizumab and irinotecan (2007) (1)
- Radioimmunotherapy treatment planning based on radiation absorbed dose or patient size (1996) (1)
- Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin. (1994) (1)
- Progress Update on the Development of the $^{3}$He Linac for PET Isotope Production (1996) (1)
- Synthesis and radioiodinatton of aryl‐carbohydrate compounds for attachment to monoclonal antibodies (1989) (1)
- Radioligands that bind to cell-specific receptors: Asialoproteins for hepatic scintigraphy (1979) (1)
- 455 Role of Hypoxia Imaging with [F-18]FMISO-PET and BOLD-MRI in Clinical Trials (2012) (1)
- 456 FES PET is an Imaging Biomarker of Pharmacodynamic Response to Estrogen Receptor (ER) Modulating Therapies in Breast Cancer (2012) (1)
- Imaging tumor hypoxia using positron emission tomography imaging of [F-18] fluoromisonidazole: A report of work during the astro research year (1989) (1)
- Use of short-lived radionuclides in the agricultural and environmental sciences (1985) (1)
- Clinical trial of I-123-bleomycin for tumor detection (1978) (1)
- PET FES measures in vivo pharmacodynamics of endocrine therapy (2007) (1)
- A physiological model for representation of tracer activity in re-circulating venous and arterial blood (2011) (1)
- Standards for Reporting PET Clinical Trials (2013) (1)
- A comparison of 15O gas production from a water target using pulsed 3HE beam and a continuous 1H beam (1999) (1)
- Oncologic Drug Development The Progress and Promise of Molecular Imaging Probes in (2005) (1)
- Sensors for indication of evaporation of solvents: Experience at the Univ. of Washington (1994) (1)
- Detection of Proliferation in Gliomas by Positron Emission Tomography Imaging (2006) (1)
- Correlation of Bioscintigraphy, Contrast Venography, and lodine-125 Fibrinogen Uptake Test (1985) (1)
- Tumor Hypoxia Imagingwith [F-18] Fluoromisonidazole Positron EmissionTomography in Head and Neck Cancer (2006) (1)
- Reactions of recoil iodine formed by the $sup 123$Xe $Yields$ $sup 123$I system with simple hydrocarbons, II. Pressure studies on the methane and ethane systems (1973) (1)
- Hot atom chemistry and radiopharmaceuticals (2012) (1)
- 2614 : Parametric Images Derived From Kinetic Modeling of Dynamic [F-18] FMISO PET - Evaluating the Feasibility of IMRT Based Dose Escalation to Hypoxic Sub-Volumes (2006) (1)
- The advantage of protecting the antigen-binding site during antibody labeling. (1991) (1)
- Abstract P4-01-02: The role of FLT PET early assessment of response to endocrine therapy for early stage breast cancer (2013) (1)
- P27 14 WP – [F-18]FLUOROMISONIDAZOLE IMAGING OF HUMAN TUMOR HYPOXIA (1991) (1)
- The biological behavior of I fibrinogen labeled by four methods of iodination (1973) (1)
- A phase II clinical trial of HDACi (vorinostat) and AI therapy in breast cancer with molecular imaging correlates. (2014) (1)
- Vivo fate of nitrogenous air pollutant derivatives - Report 3 (Project Title). Final report Aug 80-Feb 82 (1982) (0)
- Prognostic value of spatial heterogeneity in FMISO-PET images of hypoxia in brain cancer patients (2014) (0)
- P08 18 SP – THIOL PROBES FOR REDOX IMAGING USING NMR (1991) (0)
- Reproducibility of 18F-fluoromisonidazole in contralateral brain of glioma patients before and after radiotherapy (2008) (0)
- Abstract P1-01-07: The role of18F-Fluoroestradiol (FES) and18F-Fluorodeoxyglucose (FDG) PET imaging in identification of bone metastases in metastatic breast cancer (2020) (0)
- 1-[11C] Acetate model for membrane biosynthesis in glioma patients (2011) (0)
- FES PET biomarkers to predict benefit from endocrine therapy (2013) (0)
- 650 Multiparameter PET imaging for assessing risk/outcome in sarcoma (2010) (0)
- A modified FBP algorithm for reconstruction of images when there are high activity regions in the field of view (2014) (0)
- Aebersold AwardWinner Recognized forDevelopment of NovelRadiopharmaceuticals (1996) (0)
- MR Measurement of Thiol Reduction-Oxidation State in Tumor Therapy Response (1992) (0)
- PET strategies to select patients for experimental cancer therapy, invited (2008) (0)
- Biological basis of tumor imaging with radiolabeled glucose analogs (1984) (0)
- Technetium-99mGalactosyl Neoglycoalbumin: Preparation andPreclinicalStudies (1985) (0)
- 2-Iododesmethylimipramine: Synthesis and evaluation as a flow marker (1985) (0)
- Evaluation of Coronary Perfusion by Positron Emission Tomography (1993) (0)
- Abstract PD6-10:18F-fluoroestradiol (fes) and18f-fluorodeoxyglucose (fdg) pet imaging in metastatic lobular breast cancer (2021) (0)
- A Patlak-guided approach to extracting AIF information from regions with significant tracer retention (2015) (0)
- 453 [F-18] Fluorothymidine (FLT) PET Imaging of Response of Acute Myeloid Leukemia to Chemotherapy (2012) (0)
- Cryptate complexes for generator-based imaging of blood flow (1991) (0)
- Abstract B150: Are MRI/MRS methods complementary to FMISO-PET for evaluating hypoxia. (2013) (0)
- Hypoxia assessed with [F-18]-fluoromisonidazole (FMISO) PET before radiotherapy (RT) in malignant gliomas (2006) (0)
- 235 Kinetic analysis of dynamic 11C thymidine PET imaging studies: Compartmental and nonparametric approaches (2014) (0)
- More collaboration needed between drug development and imaging communities. (2001) (0)
- MR methods are complementary to FMISO-PET for imaging hypoxia (2013) (0)
- 13C NMR tracer technique for in vivo measurements of tissue redox state (1988) (0)
- Sites of direct and indirect halogenation of proteins (1977) (0)
- Experimental radioimmunotherapy with I-131-antibody against a differentiation antigen (1985) (0)
- Validation of a disposable, closed system for radiolabeling of monoclonal antibodies with high dose Iodine-131 (2007) (0)
- The fate of Cu(II)ATSM in vivo is based on reaction with thiols (2012) (0)
- High-Levellodinationof MonoclonalAntibodyFragmentsfor Radiotherapy (2006) (0)
- Validation of a kinetic model for receptor-mediated uptake of Tc-99m-galactosyl-neoglycoalbumin (Tc-NGA) (1984) (0)
- Alternative strategies for production of PET radionuclides, invited (2008) (0)
- Parametric image analysis of FLT data shows spatial differences between transport and proliferation (2013) (0)
- Abstract B147: Tumor response imaging with [F-18] fluorothymidine (FLT). (2013) (0)
- Abstract P4-01-03: HDACi (vorinostat) in metastatic breast cancer to restore sensitivity to ER-directed (AI) therapy: A phase II clinical trial with FES imaging correlates (2013) (0)
- Molecular Imaging to Guide Targeted Therapy (2006) (0)
- Assessment of cellular proliferation in recurrent primary brain cancer with 3'-deoxy-3'-18F-fluorothymidine PET imaging. (2016) (0)
- Local Recurrence and Progression Is Spatially Correlated With Focal Pretreatment FMISO PET Uptake in Head and Neck SCC (2013) (0)
- Cryptate complexes of generator produced isotopes for measurement of blood flow (1984) (0)
- Inhibition of Lens Opocificotion in X-lrrodioted Rots Treoted With WR-77913 (2005) (0)
- TC‐99M GALACTOSYL‐NEOGLYCOALBUMIN (TC‐NGA): A PREDICTOR OF FUNCTIONING HEPATOCYTE MASS.: C3 (1983) (0)
- Abstract B149: Quantitative FMISO imaging to assess regional tumor hypoxia as a predictor of response to therapy. (2013) (0)
- 261 A Fully Automatic Procedure for Image Derived Blood Extraction, Including Assessment of Metabolite, in Dynamic PET Fluorothymidine (FLT) Studies (2012) (0)
- BrainPET Poster Session: Kinetic Modeling (2009) (0)
- UW Translational Imaging Biomarker and Therapeutic Development (2018) (0)
- Molecular Imaging Guided Radiotherapy (2006) (0)
- BOLD-MR imaging of tumors is complementary to FMISO-PET (2012) (0)
- Abstract PD4-10:18F-fluoroestradiol (FES) and18F-fluorodeoxyglucose (FDG) PET imaging in staging extent of disease in metastatic lobular breast cancer (2019) (0)
- Validation of an image derived blood time course extraction method for quantitation of dynamic PET [F-18]-Fluorothymidine (FLT) studies in brain cancer patients (2013) (0)
- In vivo fate of nitrogenous air pollutant derivatives. Report No. 2 (final) 1979-80 (1980) (0)
- Quantitative structure-activity analysis of hepatobiliary agents (1980) (0)
- Metabolic analysis of dynamic PET studies using non-parametric residues and image derived arterial input functions (2009) (0)
- 616 Imaging heterogeneity of hypoxia: spatial and temporal (2010) (0)
- Use of Tc-99m-galactosyl-neoglycoalbumin (Tc-NGA) to determine hepatic blood flow (1984) (0)
- RADIOCHEMISTRY OF Zr‐89 AS A POSITRON LABEL FOR ANTIBODIES;: P1 (1987) (0)
- MOLECULAR IMAGING GUIDED RADIOTHERAPY Resistance Factors and Response to Treatment (2006) (0)
- Imaging Cellular Proliferation as a Measure of Response to Therapy (2001) (0)
- Cyclotron production of /sup 13/N compounds for environmental and biological research (1977) (0)
- Radioprotection in Rat Spinal Cord with WR2721, WR77913 and WR3689 Following Cerebral Lateral Ventricular or Intracisternal Administration (1987) (0)
- Preparation and chemical characterization of I bleomycin (1975) (0)
- Synthesis of iodovinylmisonidazole for imaging hypoxia (1991) (0)
- Imaging acute myeloid leukemia with [F-18] fluorothymidine PET (2013) (0)
- Abstract P6-04-03: Changes in breast tumor metabolism and estradiol binding as measured by FES PET in patients treated with the histone deacetylace inhibitor vorinostat and aromatase inhibitor therapy (2012) (0)
- Positron Emission Tomography (PET) for Imaging Body Chemistry (2001) (0)
- High Dose Radiolabeled Antibody Therapy of Lymphoma 1 (2006) (0)
- 531 POSTER Hypoxia assessed in malignant gliomas with [F-18]-fluoromisonidazole (FMISO) PET before and after radiotherapy (RT) (2006) (0)
- 18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study (2021) (0)
- REACTIONS OF RECOIL IODINE FORMED BY THE (123)XE-(123)I SYSTEM WITH SIMPLE HYDROCARBONS PART 2, PRESSURE STUDIES ON THE METHANE AND ETHANE SYSTEMS (1973) (0)
- Evaluation of PET and MR measurements to examine progression in glioma patients (2014) (0)
- RADIOPROTECTION IN RAT SPINAL CORD WITH WR3689: 186 (1987) (0)
- Quantifying the impact of antiangiogenic therapy on hypoxia and implications for radiation therapy in glioblastoma multiforme with a biomathematical model. (2013) (0)
- PET IMAGING WITH C‐11 THYMIDINE: DEVELOPMENT OF BIOCHEMICAL AND KINETIC MODELS.: P31 (1988) (0)
- Positron Emission Tomography Imaging of Tumor Hypoxia and Angiogenesis: Imaging Biology and Guiding Therapy (2008) (0)
- SU‐FF‐J‐106: FMISO‐PET Hypoxia Imaging: A Novel Method to Plan IMRT‐Based Boost Radiation to Hypoxic Subvolumes (2005) (0)
- Short-lived radionuclides in chemistry and biology : based on a symposium (1981) (0)
- About this journal. (2012) (0)
- Semi-automatic Dispensing System for 111In/90Y-labeled Monoclonal Antibodies:Potential for RIT & PRIT applications (2015) (0)
- Binding of radiolabeled misonidazole in cerebral infarction (1985) (0)
- Risk assessment in high grade sarcoma patients during neoadjuvant chemotherapy using multiple tracer PET. (2006) (0)
- Functional hepatic imaging following hepatic irradiation in dogs (1989) (0)
- ANTIBODY LABELING WITH A RADIOIODINATED INTRACELLULARITY TRAPPED LIGAND‐TYRAMINECELLOBIOSE (TCB).: P2 (1987) (0)
- RenalClearanceandExtractionParametersof ortho-iodohippurate(I-123) Comparedwith OIH(l-.131) andPAH (2006) (0)
- 234 Kinetic analysis of dynamic 11C-verapamil PET study: Compartmental v adaptive mixture models comparison (2014) (0)
- The effects of 5-fluorouracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells (2012) (0)
- BROMOMISONIDAZOLE AS A PROBE FOR IMAGING HYPOXIC CELLS.: I6 (1983) (0)
- Measuring functioning hepatocytes using Tc-99m galactosylneoglycoalbumin (Tc-NGA) (1984) (0)
- FMISO PET uptake and spatial heterogeneity to predict response in patients with cervical cancer (2015) (0)
- A complementary radiopharmaceutical and mathematical model for quantitating hepatic-binding protein receptors (2017) (0)
- Predictive simulation of patient-specific [18F]FMISO-PET images (2011) (0)
- Deiodination and solidification of radioassay waste (1982) (0)
- A GAMMA LABELED PLASMA FLOW MARKER: F8 (1983) (0)
- An examination of a threshold-volume characteristic for heterogeneity assessment in human sarcomas imaged with FDG-PET (2009) (0)
- [F-18] FMISO PET hypoxia imaging in cervical cancer: Pretherapy uptake in predicting survival. (2007) (0)
- Patterns of F-18 FDG uptake in head and neck cancer with lymph node metastases: Complex mechanism dictated by tumor biology? (2007) (0)
- Heterogeneity in ER binding, measured in vivo by FES PET (2009) (0)
- Molecular blood flow marker (1985) (0)
- Measurement of carrier NH3 in ammonia N13 injection (2013) (0)
- Quantitative [F-18]-fluoromisonidazole (FMISO) imaging of hypoxia in brain cancer patients (2013) (0)
- 197 Statistical aspects of kinetic analysis of gliomas with FDG-PET (2014) (0)
- Effect of cellular medium composition on Cu(II)ATSM metabolism by the A549 cell line (2015) (0)
- 461 INVITED Hypoxia imaging (2008) (0)
- Binding of aminoalkylphosphorothioate drugs to rodent tissue proteins (1989) (0)
- Comparison of radiolabeled bromomisonidazole and misonidazole as probes for hypoxic tissue (1984) (0)
- CLINICAL INVESTIGATION Head and Neck FDG-PET/CT IMAGING FOR PRERADIOTHERAPY STAGING OF HEAD-AND-NECK SQUAMOUS CELL CARCINOMA (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kenneth A. Krohn?
Kenneth A. Krohn is affiliated with the following schools:
